Cellectis Announces Participation in Five Investor Conferences

Published on August 26, 2021 in New York, NY

Back to all press releases

August 26, 2021 – New York – Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing platform company with clinical-stage immuno-oncology programs using allogeneic chimeric antigen receptor (CAR)-T cells and gene therapy programs for monogenic diseases, today announced that management plans to participate in five virtual investor conferences.

11th Annual Biotech Symposium (Goldman Sachs)

Date: Tuesday, September 7, 2021

Time: 8AM-6PM (GMT)

Citi’s 16th Annual Biopharma Conference 2021
Date: Thursday, September 9, 2021

Time: 10:40AM ET

Wells Fargo Healthcare Conference

Date: Friday, September 10, 2021

Time: 9:20AM ET

H.C. Wainwright 23rd Annual Global Investment Conference

Date: Monday, September 13, 2021

Time: 7AM ET

Baird 2021 Global Healthcare Conference

Date: Wednesday, September 15, 2021

Time: 9:05 AM ET

Live webcasts of these events and a replay of these webcasts will be available under the “Events and Webcasts” section on the Investor page of the of the Company’s at website: https://www.cellectis.com/en/investors/events-and-webcasts/

Download the PDF file